March 2026 Research Update

This month added early evidence that some immune cell expansions that can look like large granular lymphocytic leukemia may instead reflect the immune system reacting to infection, and that adding one marker may help tell the difference. In patients with CMV viremia, a flow test that includes NKG2C more often pointed to reactive "adaptive" NK cells rather than a true cancerous NK-cell clone. The main message is that infection-driven changes can mimic leukemia-like patterns, and more specific testing may reduce confusion in certain clinical situations. [1]

In this report, NKG2C was described as common in reactive adaptive NK cells that can expand during CMV infection, while it was uncommon in neoplastic NK-cell proliferations that have recurrent molecular or chromosome abnormalities. The authors described NK cell cases that met criteria for NK-LGLL but appeared to be non-neoplastic adaptive NK expansions in the setting of CMV viremia. Put simply, this study suggests that NKG2C may act like a "reactive-to-infection" signal more than a "cancer clone" signal in this setting. [1]

For patients and caregivers, this mainly adds understanding about why diagnosing LGL disorders can be complicated when certain infections are present. The work is exploratory and focused on a specific situation (CMV viremia), so it does not by itself change what any one person has. It does clarify a practical idea: adding NKG2C to a flow cytometry panel might help avoid mislabeling some infection-related NK-cell expansions as leukemia, but it still needs confirmation in broader patient groups. [1]

This month included a single case showing how T-cell large granular lymphocytic leukemia (T-LGL) can present as severe neutropenia in someone who is already immunocompromised for other reasons. The report described an HIV-positive man who came to care with fever and bacterial bloodstream infection, and later had a bone marrow exam pointing to T-LGL as a contributor to his profound low neutrophil count. The key lesson is that in complex immune situations, multiple causes can overlap, and confirming T-LGL may require bone marrow testing and immune-cell testing rather than relying on symptoms alone. [2]

In this case, the patient had a very low neutrophil count that did not improve immediately with several doses of G-CSF, but later recovered. The workup also noted a positive Strongyloides blood test and treated infections, alongside confirmation of a clonal T-cell population on specialized testing. Because it is one person, the report cannot show how often this happens, but it provides a concrete example of the diagnostic complexity around neutropenia and T-LGL in the setting of HIV and co-infections. [2]

For patients and caregivers, this case mainly matters as an illustration rather than proof of a broader pattern. It suggests that when severe neutropenia occurs in an immunocompromised person, clinicians may sometimes investigate for an underlying blood cancer like T-LGL and also look for infections that can contribute to symptoms. What remains uncertain is how common this overlap is and whether the same course would occur in other people, since a single case cannot answer those questions. [2]